Amanote Research
Register
Sign In
rhGM-CSF Ameliorates Neutropenia in Patients With Malignant Glioma Treated With BCNU
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1994.98
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 1, 1994
Authors
R Rampling
W Steward
J Paul
MA Macham
E Harvey
D Eckley
Publisher
Springer Science and Business Media LLC
Related search
Seizures in Patients With Glioma Treated With Phenytoin and Levetiracetam
Journal of Neurosurgery
Surgery
Neurology
Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated With Cetuximab
Drugs in R and D
Pharmacology
The Role of Sargramostim (rhGM‐CSF) as Immunotherapy
Oncologist
Cancer Research
Medicine
Oncology
Treatment of Malignant Glioma With Neocarzinostatin
Neurologia Medico-Chirurgica
Surgery
Neurology
Stable Long-Term Risk of Leukaemia in Patients With Severe Congenital Neutropenia Maintained on G-CSF Therapy
British Journal of Haematology
Hematology
Pcn65 - Long- Term Survival Among Patients With High-Grade Glioma Treated With Nimotuzumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
NGR-hTNF in Previously Treated Patients With Malignant Pleural Mesothelioma (MPM) .
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Radiotherapy Improves Survival in Elderly People With Malignant Glioma
BMJ
Phagocytic Function in Neutropenic Neonates Treated With G-CSF
Pediatric Research
Child Health
Pediatrics
Perinatology